Hillel has a proven track record as a key adviser to leading Canadian and foreign companies on their transactional matters. Clients in diverse sectors, including life sciences, value his thorough understanding of their businesses, his responsiveness and his pragmatic approach to challenging and time-sensitive transactions. His expertise in business acquisitions transcends borders – clients regularly choose him as lead counsel in their global M&A activities. Hillel has been a long-time counsel to several of Canada’s leading specialty pharmaceutical companies. Hillel is a member of our firm-wide Finance Committee. Select Recognition: Chambers Canada; IFLR1000; Lexpert Special Edition: Health Sciences, M&A; The Canadian Legal Lexpert Directory; The Best Lawyers in Canada.
